GlyCylic®’s vehicle (glycolic acid) works to break the bonds between the outer layers of the wart, including dead skin cells, and open pathways for the Salicylic Acid to achieve deep penetration.
GlyCylic® - is the first wart remover formulated with salicylic acid (a beta-hydroxy acid), glycolic acid (an alpha-hydroxyl acid), and immunomodulatory, virucidal, anti-scarring, and antiseptic ingredients that condition the emerging skin and promote healing while minimizing swelling, irritation, inflammation, and scarring.
The White House has announced that it will end the two-year-old COVID-19 vaccine requirement for federally funded health-care facilities and other groups.
Power Diary, an award-winning practice management software built to streamline your day-to-day operations with client management, scheduling, billing, and more - has taken things one step further with ISO 27001 certification. This certification ensures your information is secure. Save time and money with Power Diary's intuitive features! Experience the convenience of a secure, automated practice.
CMS is accepting applications for its 2023 MIPS Extreme and Uncontrollable Circumstances Exception as well as for the MIPS Promoting Interoperability Performance Category Hardship Exception.
Editor's note: Members may contact APMA Registry Manager Richard Schwarz at registry@apma.org or 301-581-9281 with MIPS questions.
